Effect of beta-adrenergic blockade on weight changes in patients with chronic heart failure

Patients with CHF due to LVSD who receive beta-blocker were less likely to develop cachexia and more likely to have significant weight gain and better outcome compared to patients who did not receive or tolerate beta-blocker.